Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chabner

Showing results (241-250 of 456) with videos related to

Pageof 46
Sort By:
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1988
AntimetabolitesC J Allegra, J L Grem, G C Yeh, et al.
The American Journal of Clinical Nutrition|July 1, 1971
Anergy and tryptophan metabolism in Hodgkin's diseaseV T DeVita, B A Chabner, D M Livingston, et al.
Blood|November 1, 1975
Deoxycytidine kinase: properties of the enzyme from human leukemic granulocytesC N Coleman, R G Stoller, J C Drake, et al.
Cancer Treatment Reports|March 1, 1978
Initial clinical trials of maytansine, an antitumor plant alkaloidB A Chabner, A S Levine, B L Johnson, et al.
Cancer Treatment Reports|June 1, 1985
Competitive protein-binding assay for trimetrexateJ C Drake, C J Allegra, G A Curt, et al.
Plastic and Reconstructive Surgery|February 3, 2011
An 8-year experience of direct-to-implant immediate breast reconstruction using human acellular dermal matrix (AlloDerm)C Andrew Salzberg, Andrew Y Ashikari, R Michael Koch, et al.
Clinical Pharmacology and Therapeutics|July 1, 1979
Presence of 2,4-diamino-N10-methylpteroic acid after high-dose methotrexateR C Donehower, K R Hande, J C Drake, et al.
Cancer Treatment Reports|July 1, 1977
Dose-dependent metabolism of methotrexate in man and rhesus monkeysS A Jacobs, R G Stoller, B A Chabner, et al.
Cancer Treatment Reports|January 1, 1986
Potential roles for preclinical pharmacology in phase I clinical trialsJ M Collins, D S Zaharko, R L Dedrick, et al.
The Journal of Clinical Investigation|February 1, 1976
7-Hydroxymethotrexate as a urinary metabolite in human subjects and rhesus monkeys receiving high dose methotrexateS A Jacobs, R G Stoller, B A Chabner, et al.
Pageof 46

Showing results (241-250 of 456) with videos related to

Sort By:
Pageof 46
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1988
AntimetabolitesC J Allegra, J L Grem, G C Yeh, et al.
The American Journal of Clinical Nutrition|July 1, 1971
Anergy and tryptophan metabolism in Hodgkin's diseaseV T DeVita, B A Chabner, D M Livingston, et al.
Blood|November 1, 1975
Deoxycytidine kinase: properties of the enzyme from human leukemic granulocytesC N Coleman, R G Stoller, J C Drake, et al.
Cancer Treatment Reports|March 1, 1978
Initial clinical trials of maytansine, an antitumor plant alkaloidB A Chabner, A S Levine, B L Johnson, et al.
Cancer Treatment Reports|June 1, 1985
Competitive protein-binding assay for trimetrexateJ C Drake, C J Allegra, G A Curt, et al.
Plastic and Reconstructive Surgery|February 3, 2011
An 8-year experience of direct-to-implant immediate breast reconstruction using human acellular dermal matrix (AlloDerm)C Andrew Salzberg, Andrew Y Ashikari, R Michael Koch, et al.
Clinical Pharmacology and Therapeutics|July 1, 1979
Presence of 2,4-diamino-N10-methylpteroic acid after high-dose methotrexateR C Donehower, K R Hande, J C Drake, et al.
Cancer Treatment Reports|July 1, 1977
Dose-dependent metabolism of methotrexate in man and rhesus monkeysS A Jacobs, R G Stoller, B A Chabner, et al.
Cancer Treatment Reports|January 1, 1986
Potential roles for preclinical pharmacology in phase I clinical trialsJ M Collins, D S Zaharko, R L Dedrick, et al.
The Journal of Clinical Investigation|February 1, 1976
7-Hydroxymethotrexate as a urinary metabolite in human subjects and rhesus monkeys receiving high dose methotrexateS A Jacobs, R G Stoller, B A Chabner, et al.
Pageof 46